Dipeptidyl peptidase-4 inhibition prevents nonalcoholic steatohepatitis-associated liver fibrosis and tumor development in mice independently of its anti-diabetic effects.
Kawakubo M, Tanaka M, Ochi K, Watanabe A, Saka-Tanaka M, Kanamori Y, Yoshioka N, Yamashita S, Goto M, Itoh M, Shirakawa I, Kanai S, Suzuki H, Sawada M, Ito A, Ishigami M, Fujishiro M, Arima H, Ogawa Y, Suganami T.
Kawakubo M, et al. Among authors: goto m.
Sci Rep. 2020 Jan 22;10(1):983. doi: 10.1038/s41598-020-57935-6.
Sci Rep. 2020.
PMID: 31969650
Free PMC article.